Refine by
Emergencies Health Care Articles & Analysis
34 news found
Entegrion Announces CE Mark for Point of Care System for Blood Coagulation Monitoring. Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. DURHAM, N.C. (PRWEB) January 19, 2018 — Entegrion, Inc. today announced that it has achieved CE mark for the Company’s portable ...
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). ...
Their responses included: Reducing IV restarts Less trauma to patients by reducing restart-related needlesticks Preserving patient veins for subsequent procedures Maintaining IV access in emergency and critical care situations, and when transporting patients Lowered costs due to less waste of IV supplies. ...
The oxygen generator also has the advantage of convenient transportation, which brings convenience to users and medical and health workers. The oxygen generator can support the treatment of severe patients with coronavirus disease. ...
SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the group’s new Chief Commercial Officer for its US business. Thomas is an accomplished commercial leader with more than 25 years of US and global experience across large and mid-sized biopharmaceutical companies. His career includes a wide range of roles in marketing, sales, operations, ...
SERB is pleased to announce it has acquired the rights from Ipsen to commercialize Xermelo® (telotristat ethyl) in Europe and other countries outside the US and Japan. Financial terms of the transaction were not disclosed. Xermelo is indicated for the treatment of carcinoid syndrome diarrhoea (CSD) in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by ...
The AscencioDx represents a new generation of point-of-care molecular diagnostic testing that enables highly accurate results in about 30 minutes. ...
Manufacturer of the revolutionary XSTAT technology will now have a second sterile wound dressing available in Europe and other International markets. RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in Europe. XGAUZE, a Class I sterile ...
ByRevMedx
Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON. ...
SERB and BTG Specialty Pharmaceuticals announced that the European Commission has granted marketing authorisation for Voraxaze (glucarpidase) to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity. Voraxaze is now authorized for marketing in all members states of the European Union ...
The first evidence of high dose methotrexate related toxicity (HDMTX) in Spain was presented today at Virtual ISPOR Europe 2021, a global conference on healthcare economics and outcomes. Xavier Badia, MD, MPH, PhD of Omakase Consulting S.L. presented the poster titled “Epidemiology and Clinical Management of Patients with Methotrexate Toxicity in Spain Using the Delphi Technique,” ...
In patients with methotrexate concentrations measured by chromatographic methods, a median reduction of > 97% in methotrexate concentration occurred within 15 minutes following Voraxaze® administration. , The CHMP approval follows the news earlier this year that Japan’s Ministry of Health, Labour and Welfare authorized glucarpidase to be sold in Japan as ...
SERB and BTG Specialty Pharmaceuticals are pleased to announce that Ben Watt has been named the group’s new Chief Financial Officer. Ben is an experienced CFO with a track record of building global finance teams and integrating business acquisitions. Ben most recently served as CFO of Crouzet, an independent manufacturer of electronic components used in heavily regulated industries. He ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Sapporo Medical University Hospital, located in Hokkaido, Japan, has entered into an agreement to lease and utilize a Senhance® Surgical System. “The Department of Surgery, ...
BTG Specialty Pharmaceuticals announced that Ohara Pharmaceutical Co., Ltd. has obtained marketing authorization for glucarpidase from Japan's Ministry of Health, Labour and Welfare as a therapeutic agent for “detoxication in case of delayed methotrexate elimination with methotrexate-leucovorin rescue therapy,” on September 27, 2021. Ohara will sell glucarpidase in ...
As the leader in vein visualization technology throughout the world, Christie’s high-quality, made-in-the USA, VeinViewer®Vision2 and VeinViewer® Flex, continue to provide customers with improved clinical outcomes such as increasing 1st stick success, decreasing medically not required PICC lines and enhancing patient satisfaction. We are committed to the continued growth of ...
VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung’s Premium Mobile X-ray System VUNO’s road-tested, clinically-proven chest X-ray detection software is reshaping the delivery of medical imaging diagnostics by being fully integrated with Samsung Electronics’ X-ray system June 25, 2021 - South Korean artificial intelligence (AI) developer, VUNO ...
In the recently published RedHeart Study the Coala Heart Monitor was used to remotely monitor 821 women with palpitation issues for 60 days. Over 200,000 individual ECG strips were analyzed. The direct ECG response of the Coala Heart Monitor contributed to reduced levels of anxiety, depression and symptoms of palpitations. The direct ECG response of the Coala also led to an increased quality of ...
KEY POINTS Cardiac arrest is one of the leading causes of death in the U.S. and globally. It has a survival rate of 1 in 10 people with current treatment. The Neurescue device is designed to increase blood flow to the brain and heart during life-threatening emergencies such as cardiac arrest. Cardiac arrest is one of the leading causes of death around the world, ...
Vygon specializes in the development and commercialization of medical devices that are used by healthcare professionals in multiple clinical areas, in particular intravascular therapies, anesthesia and emergency care, as well as cardiology and vascular surgery. Oncomfort has created its digital therapy to reduce pain and anxiety for patients in these clinical ...